Aug. 12 at 9:08 PM
$LXRX I don't concern myself with share prices, there are millions of traders and their behavior dictates the price, but I will call out pumpers with ridiculous price predictions. I cant tell you the share price one year from now, otherwise I would be beyond wealthy. 1 year from now has countless variables, it's not like this is a stable, growing company, it's a speculative company that derives it income from partnerships and not drug sales revenue. As for selling Zyn, they already had approval to sell it in Europe and sales were so poor their partner Sanofi terminated the deal, and sales of Inpefa along with their 2nd FDA rejection of Zyn caused the company to terminate their entire sales and marketing departments. As for filing an NDA for HCM, they can't, they need to clean their data, analyze it and submit it(can take many months). I don't have a position, but I have been trading LXRX since about 2023, I would buy again if it drops below
$1.50, but I'm on here fun.
